Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b RCT of AZD7594 DPI in Symptomatic Asthma on Low-dose ICS
jRCT2080224114Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing AZD7594 DPI once daily with Placebo DPI once daily (2 arms). Started Oct 2018; status: completed.
02
Drugs
velsecorat
03
Conditions
asthma
Beyond the preview
Go deeper on jRCT2080224114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224114.